Ingrid Garajová
Impact in
- Cancer Research top 5%
- MicroRNA in disease regulation
- Cancer-related molecular mechanisms research
- Cancer Genomics and Diagnostics
- Hepatology top 5%
- Hepatocellular Carcinoma Treatment and Prognosis
Papers in
- Co-authors
- Elisa Giovannetti (31 shared papers)Guido Biasco (14 shared papers)Godefridus J. Peters (6 shared papers)Rita Balsano (14 shared papers)Giovanni Brandi (16 shared papers)Stefania De Lorenzo (13 shared papers)Adam E. Frampton (7 shared papers)Geert Kazemier (12 shared papers)
- Journals
- Cancers (8 papers)Annals of Oncology (8 papers)Cancer Research (4 papers)Life (3 papers)European Journal of Cancer (3 papers)
- Partner nations
- ItalyNetherlandsUnited Kingdom
In The Last Decade
Ingrid Garajová
77 papers receiving 1.0k citations
Peers
Comparison fields: 5 of 86
- Cancer Research 310
- Hepatology 136
- Oncology 389
- Pulmonary and Respiratory Medicine 160
- Molecular Biology 364
Countries citing papers authored by Ingrid Garajová
This map shows the geographic impact of Ingrid Garajová's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ingrid Garajová with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ingrid Garajová more than expected).
Fields of papers citing papers by Ingrid Garajová
This network shows the impact of papers produced by Ingrid Garajová. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ingrid Garajová. The network helps show where Ingrid Garajová may publish in the future.
Co-authors
The 25 scholars most cited alongside Ingrid Garajová, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 84 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 117 | |
| 2 | 2018 | 83 | |
| 3 | 2016 | 62 | |
| 4 | 2018 | 52 | |
| 5 | 2018 | 51 | |
| 6 | 2014 | 43 | |
| 7 | 2022 | 35 | |
| 8 | 2020 | 32 | |
| 9 | 2022 | 29 | |
| 10 | 2020 | 28 | |
| 11 | 2017 | 23 | |
| 12 | 2021 | 22 | |
| 13 | 2011 | 22 | |
| 14 | 2022 | 22 | |
| 15 | 2019 | 22 | |
| 16 | 2019 | 21 | |
| 17 | 2023 | 21 | |
| 18 | 2023 | 21 | |
| 19 | 2015 | 21 | |
| 20 | 2024 | 20 |
About Ingrid Garajová
Ingrid Garajová is a scholar working on Oncology, Surgery, Cancer Research, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 84 papers that have together received 1.1k indexed citations. Recurring topics across this work include Pancreatic and Hepatic Oncology Research (24 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (19 papers), Hepatocellular Carcinoma Treatment and Prognosis (12 papers), MicroRNA in disease regulation (12 papers), Colorectal Cancer Treatments and Studies (10 papers), Cancer Genomics and Diagnostics (7 papers), RNA modifications and cancer (7 papers) and Cancer-related molecular mechanisms research (6 papers). The work is most often cited by research in Cancer Research (310 citations), Hepatology (136 citations), Oncology (389 citations), Pulmonary and Respiratory Medicine (160 citations) and Molecular Biology (364 citations). Ingrid Garajová has collaborated with scholars based in Italy, Netherlands and United Kingdom. Frequent co-authors include Elisa Giovannetti, Guido Biasco, Godefridus J. Peters, Rita Balsano, Giovanni Brandi, Stefania De Lorenzo, Adam E. Frampton, Geert Kazemier, Niccola Funel and Manuela Ferracin. Their work appears in journals such as Cancers, Annals of Oncology, Cancer Research, Life and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.